Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1231 AL 1245

Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease

Vance JM, Farrer LA, Huang Y, Cruchaga C, Hyman BT, Pericak-Vance MA, Goate AM, Greicius MD, Griswold AJ, Haines JL, Tcw J, Schellenberg GD, Tsai LH, Herz J, Holtzman DM.

Ann Neurol. 2024 Apr;95(4):625-634. doi: 10.1002/ana.26864. Epub 2024 Jan 5.

The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review

Wang X, Li H, Sheng Y, He B, Liu Z, Li W, Yu S, Wang J, Zhang Y, Chen J, Qin L, Meng X.

Biomed Pharmacother. 2024 Feb;171:116071. doi: 10.1016/j.biopha.2023.116071. Epub 2024 Jan 6.

Cell type-specific roles of APOE4 in Alzheimer disease

Blumenfeld J, Yip O, Kim MJ, Huang Y.

Nat Rev Neurosci. 2024 Feb;25(2):91-110. doi: 10.1038/s41583-023-00776-9. Epub 2024 Jan 8.

Data-driven modelling of neurodegenerative disease progression: thinking outside the black box

Young AL, Oxtoby NP, Garbarino S, Fox NC, Barkhof F, Schott JM, Alexander DC.

Nat Rev Neurosci. 2024 Feb;25(2):111-130. doi: 10.1038/s41583-023-00779-6. Epub 2024 Jan 8.

How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?

Beveridge J, Kaniecki E, Naidu A, Silverglate BD, Grossberg G.

Expert Opin Emerg Drugs. 2024 Mar;29(1):35-43. doi: 10.1080/14728214.2024.2304059. Epub 2024 Jan 12.

Neuronal and glial vulnerability of the suprachiasmatic nucleus in tauopathies: evidence from human studies and animal models

Son G, Neylan TC, Grinberg LT.

Mol Neurodegener. 2024 Jan 10;19(1):4. doi: 10.1186/s13024-023-00695-4.

Agents at the Peak of US FDA Approval for the Treatment of Alzheimer's Disease

Alam J, Kalash A, Hassan MI, Rahman SZ.

Neurol Res. 2024 Apr;46(4):318-325. doi: 10.1080/01616412.2024.2302271. Epub 2024 Jan 10.

Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease

Drakontaeidi A, Pontiki E.

Int J Mol Sci. 2024 Jan 1;25(1):582. doi: 10.3390/ijms25010582.

Targeting misfolding and aggregation of the amyloid-β peptide and mutant p53 protein using multifunctional molecules

Grcic L, Leech G, Kwan K, Storr T.

Chem Commun (Camb). 2024 Feb 1;60(11):1372-1388. doi: 10.1039/d3cc05834d.

Potential links between platelets and amyloid-β in the pathogenesis of Alzheimer's disease: Evidence from in vitro, in vivo, and clinical studies

Yubolphan R, Pratchayasakul W, Koonrungsesomboon N, Chattipakorn N, Chattipakorn SC.

Exp Neurol. 2024 Apr;374:114683. doi: 10.1016/j.expneurol.2024.114683. Epub 2024 Jan 9.

Neuropathology of patients with preclinical or early clinical Alzheimer's disease with pathogenic PSEN1_p. L392V: Comparison of advanced siblings

Hata Y, Nakase M, Ichimata S, Yoshida K, Nishida N.

Alzheimers Dement. 2024 Mar;20(3):2291-2296. doi: 10.1002/alz.13675. Epub 2024 Jan 12.

High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?

Valentin-Escalera J, Leclerc M, Calon F.

J Alzheimers Dis. 2024;97(3):977-1005. doi: 10.3233/JAD-230118.

The Catastrophe of Intracerebral Hemorrhage Drives the Capillary-Hemorrhage Dementias, Including Alzheimer's Disease

Stone J, Mitrofanis J, Johnstone DM, Robinson SR.

J Alzheimers Dis. 2024;97(3):1069-1081. doi: 10.3233/JAD-231202.

Passive immunotherapy for Alzheimer's disease

Guo X, Yan L, Zhang D, Zhao Y.

Ageing Res Rev. 2024 Feb;94:102192. doi: 10.1016/j.arr.2024.102192. Epub 2024 Jan 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias